A Pharmacokinetics and Safety Study of Augmentin ES-600 in Children With CAP and ABRS

Clinical trial NCT05340257 · WITHDRAWN

Trial details

NCT number: NCT05340257
Sponsor: GlaxoSmithKline
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Infections, Bacterial

Start date: 2023-10-14
Primary completion: 2024-07-08
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.